Abstract | PURPOSE: EXPERIMENTAL DESIGN: We have previously identified alterations in the N-linked glycosylation of serum proteins with the development of HCC and identified many of the proteins that contained the altered glycosylation. In the current study, we compared the ability of the identified proteins to diagnose HCC with the total serum glycan analysis. RESULTS: Surprisingly, glycan analysis of total serum had the greatest ability to distinguish HCC from cirrhosis with an AUROC of 0.851, a sensitivity of 73% at a specificity of 88%. When total glycan sequencing was combined with alpha-fetoprotein (AFP), the sensitivity increased to 95% at a specificity of 90%. CONCLUSION AND CLINICAL RELEVANCE: Changes in glycosylation as detected in whole serum could be used to diagnose HCC with greater sensitivity and specificity than that observed through the analysis of specific protein glycoforms or protein levels. Such an assay could have value in the management of those at risk for the development of HCC.
|
Authors | Mary Ann Comunale, Mengjun Wang, Nikhil Anbarasan, Lucy Betesh, Aykan Karabudak, Ethan Moritz, Karthik Devarajan, Jorge Marrero, Timothy M Block, Anand Mehta |
Journal | Proteomics. Clinical applications
(Proteomics Clin Appl)
Vol. 7
Issue 9-10
Pg. 690-700
(Oct 2013)
ISSN: 1862-8354 [Electronic] Germany |
PMID | 23857719
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
|
Topics |
- Animals
- Blood Chemical Analysis
- Carcinoma, Hepatocellular
(blood, diagnosis, virology)
- Early Detection of Cancer
(methods)
- Hepacivirus
(physiology)
- Hepatitis B virus
(physiology)
- Humans
- Immunoassay
- Lectins
(blood)
- Liver Neoplasms
(blood, diagnosis, virology)
- Polysaccharides
(blood)
|